Management of chronic myelogenous leukemia with COVID-19 and hepatitis B
Description
The application of immunosuppressive agents and targeted drugs has opened a novel approach for the treatment of hematological tumors, and the application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia is one of the
